Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives by Amy W. Law, Jay Lin, Jennifer Judy, Sarah J. Pugh, Alejandro Cane

Get full text

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Me... by José Luis Huerta, Robyn Kendall, Luka Ivkovic, Carlos Molina, Amy W. Law, Diana Mendes

Get full text

Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus by Mostafa Zayed, Jean Joury, Mohamed Farghaly, Sara Al Dallal, Ramya Mahendiran, Amy W. Law, Diana Mendes, Erin Quinn, Emily Kutrieb, Ahuva Averin

Get full text

Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory... by Ahuva Averin, Amy W. Law, Derek Weycker, Mark Atwood, Erin Quinn, Jessica E. Atwell, Alejandro Cane, Bradford D. Gessner, Sarah Pugh, Kimberly M. Shea

Get full text

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States by Martine C. Maculaitis, Brett Hauber, Kathleen M. Beusterien, Oliver Will, Lewis Kopenhafer, Amy W. Law, Jeffrey T. Vietri, Joseph C. Cappelleri, Joshua R. Coulter, Sarah Pugh, Kimberly M. Shea

Get full text